2022 annual financial data
Beam Therapeutics 2022 Net margin
Beam Therapeutics 2022 net margin with verified reported values.
Direct answer
Net margin was -474.54%.
Operating income was -338,479,000 USD and net income was -289,088,000 USD.
Operating cash flow was 22,527,000 USD.
Get free Beam Therapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 60,920,000 USD
- Operating income
- -338,479,000 USD
- Net income
- -289,088,000 USD
- Operating cash flow
- 22,527,000 USD